Cargando…
Schedule-dependent interaction between paclitaxel and 5-fluorouracil in human carcinoma cell lines in vitro.
We assessed the cytotoxic interaction between paclitaxel and 5-fluorouracil administered at various schedules against four human carcinoma cell lines, A549, MCF7, PA1 and WiDr. The cells were exposed simultaneously to paclitaxel and to 5-fluorouracil for 24 h or sequentially to one drug for 24 h fol...
Autores principales: | Kano, Y., Akutsu, M., Tsunoda, S., Ando, J., Matsui, J., Suzuki, K., Ikeda, T., Inoue, Y., Adachi, K. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074704/ https://www.ncbi.nlm.nih.gov/pubmed/8795571 |
Ejemplares similares
-
Schedule‐dependent Interactions between Raltitrexed and Cisplatin in Human Carcinoma Cell Lines in vitro
por: Kano, Yasuhiko, et al.
Publicado: (2000) -
Schedule‐dependent Synergism and Antagonism between Raltitrexed (“Tomudex”) and Methotrexate in Human Colon Cancer Cell Lines in vitro
por: Kano, Yasuhiko, et al.
Publicado: (2001) -
Scheduling nab-paclitaxel combined with gemcitabine as first-line treatment for metastatic pancreatic adenocarcinoma
por: Corrie, P. G., et al.
Publicado: (2020) -
The effects of ICRF-154 in combination with other anticancer agents in vitro.
por: Kano, Y., et al.
Publicado: (1992) -
Addition of 5-fluorouracil to doxorubicin-paclitaxel sequence increases caspase-dependent apoptosis in breast cancer cell lines
por: Zoli, Wainer, et al.
Publicado: (2005)